Aberdeen Group plc Cuts Stake in Revvity Inc. $RVTY

Aberdeen Group plc lessened its position in Revvity Inc. (NYSE:RVTY) by 90.0% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 10,904 shares of the company’s stock after selling 97,645 shares during the period. Aberdeen Group plc’s holdings in Revvity were worth $918,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in the company. First National Advisers LLC lifted its position in Revvity by 0.8% in the third quarter. First National Advisers LLC now owns 15,023 shares of the company’s stock valued at $1,317,000 after purchasing an additional 125 shares during the period. FWG Holdings LLC raised its stake in shares of Revvity by 2.8% during the 3rd quarter. FWG Holdings LLC now owns 6,215 shares of the company’s stock worth $592,000 after buying an additional 167 shares in the last quarter. NorthCrest Asset Manangement LLC lifted its holdings in shares of Revvity by 2.5% in the 3rd quarter. NorthCrest Asset Manangement LLC now owns 7,514 shares of the company’s stock valued at $685,000 after buying an additional 180 shares during the period. CVA Family Office LLC boosted its stake in shares of Revvity by 79.0% in the second quarter. CVA Family Office LLC now owns 410 shares of the company’s stock valued at $40,000 after buying an additional 181 shares in the last quarter. Finally, EverSource Wealth Advisors LLC grew its holdings in Revvity by 25.9% during the second quarter. EverSource Wealth Advisors LLC now owns 900 shares of the company’s stock worth $87,000 after acquiring an additional 185 shares during the period. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

RVTY has been the subject of a number of recent analyst reports. Evercore raised their target price on Revvity from $112.00 to $118.00 and gave the company an “outperform” rating in a report on Tuesday, February 3rd. Robert W. Baird set a $129.00 price target on shares of Revvity in a report on Tuesday, February 3rd. The Goldman Sachs Group started coverage on shares of Revvity in a report on Tuesday, December 9th. They set a “neutral” rating and a $105.00 price objective on the stock. JPMorgan Chase & Co. increased their target price on shares of Revvity from $100.00 to $105.00 and gave the company a “neutral” rating in a report on Tuesday, February 3rd. Finally, Bank of America downgraded shares of Revvity from a “buy” rating to a “neutral” rating and set a $110.00 price target for the company. in a research report on Monday, December 15th. Five equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $113.67.

Revvity Stock Performance

NYSE:RVTY opened at $100.37 on Friday. The company has a current ratio of 1.68, a quick ratio of 1.40 and a debt-to-equity ratio of 0.36. The company has a market capitalization of $11.38 billion, a P/E ratio of 48.25, a price-to-earnings-growth ratio of 2.13 and a beta of 1.07. The firm has a 50-day moving average price of $103.21 and a two-hundred day moving average price of $96.07. Revvity Inc. has a twelve month low of $81.36 and a twelve month high of $120.39.

Revvity (NYSE:RVTY) last released its quarterly earnings results on Monday, February 2nd. The company reported $1.70 EPS for the quarter, beating the consensus estimate of $1.55 by $0.15. Revvity had a net margin of 8.45% and a return on equity of 7.92%. The business had revenue of $772.06 million for the quarter, compared to analyst estimates of $759.81 million. During the same period in the prior year, the business earned $1.42 earnings per share. The company’s quarterly revenue was up 5.9% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. As a group, research analysts expect that Revvity Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity declared that its board has initiated a share buyback plan on Monday, October 27th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the company to purchase up to 8.7% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s management believes its shares are undervalued.

Revvity Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 8th. Investors of record on Friday, April 17th will be paid a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, April 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. Revvity’s dividend payout ratio (DPR) is presently 13.46%.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.